Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer

Adriamycin (ADR) is an important chemotherapy agent in many advanced cancers, but the emergence of drug resistance during treatment is a major limitation to its successful use. Recent studies have suggested that drug-resistant cells become less fit and their growth could be inhibited by parental cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi Min, Xie Lijuan, Duan Guihua
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/6cad66f315dc43448fb0063f12084c42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!